93 related articles for article (PubMed ID: 11137234)
1. Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves.
Lemaire M; Hanon E; Schynts F; Meyer G; Thiry E
Vaccine; 2000 Dec; 19(9-10):1013-7. PubMed ID: 11137234
[TBL] [Abstract][Full Text] [Related]
2. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
3. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation.
Kaashoek MJ; Moerman A; Madić J; Weerdmeester K; Maris-Veldhuis M; Rijsewijk FA; van Oirschot JT
Vaccine; 1995 Mar; 13(4):342-6. PubMed ID: 7793128
[TBL] [Abstract][Full Text] [Related]
4. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
Kaashoek MJ; van Oirschot JT
Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
[TBL] [Abstract][Full Text] [Related]
5. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
Mars MH; de Jong MC; van Oirschot JT
Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves.
Lemaire M; Schynts F; Meyer G; Thiry E
Vet Rec; 1999 Feb; 144(7):172-6. PubMed ID: 10097325
[TBL] [Abstract][Full Text] [Related]
7. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
[TBL] [Abstract][Full Text] [Related]
8. Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny.
Earley B; Tiernan K; Duffy C; Dunn A; Waters S; Morrison S; McGee M
Res Vet Sci; 2018 Jun; 118():43-51. PubMed ID: 29421483
[TBL] [Abstract][Full Text] [Related]
9. A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations.
Mars MH; de Jong MC; van Oirschot JT
Vaccine; 2000 Apr; 18(20):2120-4. PubMed ID: 10715526
[TBL] [Abstract][Full Text] [Related]
10. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
[TBL] [Abstract][Full Text] [Related]
11. Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains.
Rijsewijk FA; Kaashoek MJ; Langeveld JP; Maris-Veldhuis MA; Magdalena J; Verschuren SB; Meloen RH; van Oirschot JT
Arch Virol; 2000; 145(5):921-36. PubMed ID: 10881679
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of latent bovine herpesvirus 1 in cattle seronegative to glycoproteins gB and gE.
Hage JJ; Glas RD; Westra HH; Maris-Veldhuis MA; Van Oirschot JT; Rijsewijk FA
Vet Microbiol; 1998 Feb; 60(2-4):87-98. PubMed ID: 9646441
[TBL] [Abstract][Full Text] [Related]
13. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8.
Toussaint JF; Coen L; Letellier C; Dispas M; Gillet L; Vanderplasschen A; Kerkhofs P
Vet Res; 2005; 36(4):529-44. PubMed ID: 15955279
[TBL] [Abstract][Full Text] [Related]
16. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
17. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
Denis M; Hanon E; Rijsewijk FA; Kaashoek MJ; van Oirschot JT; Thiry E; Pastoret PP
Vet Microbiol; 1996 Nov; 53(1-2):121-32. PubMed ID: 9011004
[TBL] [Abstract][Full Text] [Related]
18. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
20. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
